Chem. J. Chinese Universities ›› 2015, Vol. 36 ›› Issue (3): 469.doi: 10.7503/cjcu20140907

• Organic Chemistry • Previous Articles     Next Articles

Synthesis, Antibacterial Activity and Molecular Simulation with FabⅠ of a Series of Novel 1,2,4-Triazolo[3,4-b]-1,3,4-thiadiazoles

WANG Meijun, LU Junrui*(), XIN Chunwei, LIU Jinbiao, MU Jiangbei, ZHANG He, ZHANG Ruibo, YANG Xuyun, WANG Hongyun   

  1. School of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin 300384, China
  • Received:2014-10-11 Online:2015-03-10 Published:2015-01-30
  • Contact: LU Junrui E-mail:lujunrui@tjut.edu.cn
  • Supported by:
    † Supported by the National Natural Science Foundation of China(Nos.21176194, 21476174)

Abstract:

Ten novel compounds of 3-alkyl/aryl-6-S-(2',3',4',6'-tetra-O-acetyl-β-D-glcopyranosyl)-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles were designed and synthesized from 3-alkyl/aryl-4-amino-5-mercapto-1,2,4-triazoles. The structures of all the compounds were confirmed by means of 1H NMR, 13C NMR, HRMS and IR. The preliminary bioassay showed that all target compounds possessed efficient antibacterial activities on Escherichia coli, Staphylococcus aureus, Bacillus subtilis and Monilia albican. Especially, the compound 3c had strong antibacterial by the lowest minimal inhibitory concentration(MIC) values on the four tested strains which were close to those of the controlled drug fluconazole. The interaction and binding free energy of the target compounds(3a—3j) with FabⅠ were studied by AutoDock 4.0.

Key words: Glucoside, 1,2,4-Triazolo[3,4-b]-1,3,4-thiadiazole, Antibacterial, FabⅠ

CLC Number: 

TrendMD: